Tag: Steven Schwartz

Browse our exclusive articles!

US Lawyer Utilizes ChatGPT for Court Filing Preparation: What Ensued?

US lawyer apologizes for a false brief submitted to a civil case involving Avianca that was generated by a chatbot. Steven Schwartz cited non-existent cases to support his litigation claim, blaming his first-time use of ChatGPT. Read more on this story.

ChatGPT’s Ability to Fabricate Cases Surprised Me

New York lawyer Steven Schwartz faces sanctions after using an AI model to create a fabricated legal brief, citing non-existent court decisions. Schwartz claimed he was duped by the tool, but his reputation has been significantly damaged. As AI and natural language processing advance, it is crucial to understand their limitations. The judge has yet to make a ruling on the sanctions.

Lawyer who Used ChatGPT to Briefly Explain Fake Cases Admits Failure

A New York lawyer used an AI tool to file a court brief with phony legal precedents. The tool admitted to providing inaccurate information. The lawyer has requested leniency, stating he had no intention to fool anyone. The judge's decision on possible sanctions remains unknown.

Lawyers confess to fabricating cases with ChatGPT, beg court for mercy

Two lawyers are appearing before a US District Judge to defend their use of an AI chatbot to generate false cases for a lawsuit. They claim it was a good faith workaround as Westlaw and LexisNexis were unavailable. The product in question was OpenAI's ChatGPT, causing some amusement. It is uncertain if one lawyer will be punished for the chatbot's production of extended excerpts and fake case quotations.

Lawyers in Trouble for Faking Opinions on ChatGPT

Lawyers under fire for faking opinions and citing non-existent cases in a lawsuit against Avianca Airlines. In-person hearing set for June 9.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img